Prenatal diagnostics is used for testing the fetus before birth to determine certain hereditary disorders, for instance, Down's syndrome, hereditary sicknesses, chromosome abnormalities, neural tube defects, and other conditions. If high-risk is identified with the birth of a child, it can be assisted by conducting hereditary testing, common testing, and screening. The United States Prenatal Diagnostic Market was valued at USD 527.5 Mn in 2017 and is expected to reach US$ 1,429.5 Mn by 2022.
United States prenatal diagnostics market is driven by various factors which includes, growing demand for non-invasive prenatal diagnostics, the ascent in detection rates of Down's syndrome, innovation headways, and increasing age of mothers which develops the possibility and risk of chromosomal abnormalities.
Top Players of United States Prenatal Diagnostic Market are Studied: Laboratory Corporation of America Holdings, Eurofins NTD, LLC, Abbott Laboratories, Hologic Inc., Illumina, Inc., Natera, Inc., PerkinElmer, Inc., Sequenom, Inc., Ariosa Diagnostics, Inc., and Ravgen. Inc. amongst others.
Click to view the full report: https://www.absolutemarketsinsights.com/reports/United-States-Prenatal-Diagnostic-Market-2018-2026-17
Prenatal Diagnostic Market, By Test Type
On the basis of test type, MaterniT21 PLUS Segment represented a major share in the U.S. Prenatal Diagnostic Market in 2016. The MaterniT21 PLUS test is indicated for use in pregnant women with increased risk for chromosomal aneuploidy. It analyzes circulating cell-free DNA extracted from a maternal blood sample. Rise in maternal age, and growing incidence of genetic abnormalities in newborns are the most significant drivers of these tests. Moreover, increased market penetration and competitive marketing methodologies by companies are further boosting the growth of these tests.
United States Prenatal Diagnostic Market
It has been reported that there are 750,000 pregnancies at high risk for fetal aneuploidy each year in the United States. The test is mainly to analyze the relative amount of 21, 18, 13, as well as X and Y chromosomal material in cell-free DNA. Increasing rate of high-risk pregnancies and rising average age for childbearing is driving the market growth particularly in developed countries such as the United States. With better advertising procedures and positioning, major companies are planning to venture in this area. Steady government research activities and increasing discretionary cash flow are some of the elements supplementing the prenatal diagnostics market in the U.S.
Objectives of the Study:
- To define, describe, and analyze the global conducting polymers market by type, application, and region
- To forecast and analyze the market size (in terms of value and volume) and submarkets in five regions such as Asia Pacific, Europe, North America, Central & South America, and the Middle East & Africa
- To forecast Country-level market and analysis for each region.
- To strategically analyze each submarket with respect to individual growth trends and its contribution to the global market of conducting polymers
- To analyze market opportunities for stakeholders by identifying fast-growing segments of the global conductive polymer market.
- To identify trends and factors that drive or hinder the growth of markets and submarkets.
- To analyze competitive developments, such as expansions, new product developments, mergers & acquisitions, and contracts & agreements in the global conducting polymers market
- Strategically profile key market players and comprehensively analyze their growth strategies.
Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +917400242424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/
No comments:
Post a Comment